NCT00331799View on ClinicalTrials.gov

Pilot Study of Duloxetine in Psychological Resilience

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

July 31, 2008

Conditions
Major Depressive Disorder
Interventions
DRUG

Duloxetine

Open label treatment with Duloxetine for 8 wks. Dose 30-60 mg.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER

NCT00331799 - Pilot Study of Duloxetine in Psychological Resilience | Biotech Hunter | Biotech Hunter